脓毒症中的坏死性凋亡、焦亡与铁死亡及其治疗
脓毒症是感染启动、持续过度炎症直至免疫抑制的稳态失衡,全球疾病负担重、死亡率高,临床研究未获 promising 结果。近年调节性细胞死亡(RCD)机制受到关注,濒死细胞释放大量危险信号参与炎症反应并加重脓毒症。本文总结脓毒症中坏死性凋亡、焦亡、铁死亡等RCD形式。结论认为靶向RCD是治疗脓毒症有前景的途径。
要点
- 脓毒症定义为感染启动、持续过度炎症直至免疫抑制的稳态失衡,全球死亡率仍高。
- 临床脓毒症识别与管理虽有进展,但临床试验未能取得 promising 结果。
- 坏死性凋亡、焦亡、铁死亡等调节性细胞死亡释放大量危险信号,参与炎症反应并加重脓毒症。
- 作者认为靶向调节性细胞死亡是治疗脓毒症有前景的途径。
研究设计与关键结果
- 综述总结脓毒症中坏死性凋亡、焦亡、铁死亡等调节性细胞死亡(RCD)形式的机制。
- 脓毒症由感染启动,随后持续过度炎症直至免疫抑制,表现为稳态失衡。
- 濒死细胞释放大量危险信号,参与炎症反应并加重脓毒症。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为靶向调节性细胞死亡是治疗脓毒症有前景的途径。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
As a global major health problem and a leading cause of death, sepsis is defined as a failure of homeostasis, which is mainly initiated by an infection and followed by sustained excessive inflammation until immune suppression. Despite advances in the identification and management of clinical sepsis, morbidity, and mortality remain high. In addition, clinical trials have failed to yield promising results. In recent years, the mechanism of regulated cell death (RCD) in sepsis has attracted more and more attention, because these dying cells could release a large number of danger signals which contribute to inflammatory responses and exacerbation of sepsis, providing a new direction for us to make treatment strategy. Here we summarize mechanisms of several forms of RCD in sepsis including necroptosis, pyroptosis, ferroptosis. In conclusion, targeting RCD is considered a promising approach to treat sepsis.
参考来源
- Qu M, Wang Y, Qiu Z, et al. Necroptosis, Pyroptosis, Ferroptosis in Sepsis and Treatment. Shock. 2022. PMID: 35759299. doi:10.1097/SHK.0000000000001936
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。